Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:EIDX

Eidos Therapeutics (EIDX) Stock Price, News & Analysis

Eidos Therapeutics logo

About Eidos Therapeutics Stock (NASDAQ:EIDX)

Advanced Chart

Key Stats

Today's Range
$122.21
$122.21
50-Day Range
$120.98
$128.51
52-Week Range
$28.39
$132.54
Volume
N/A
Average Volume
128,113 shs
Market Capitalization
$4.75 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive EIDX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Eidos Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

EIDX Stock News Headlines

This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.
The Anglo File: Game Over for Board Lapses at Eidos
See More Headlines

EIDX Stock Analysis - Frequently Asked Questions

Eidos Therapeutics, Inc. (NASDAQ:EIDX) posted its quarterly earnings results on Thursday, October, 29th. The company reported ($0.79) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.71) by $0.08. The firm had revenue of $0.13 million for the quarter.

Eidos Therapeutics (EIDX) raised $101 million in an IPO on Wednesday, June 20th 2018. The company issued 6,300,000 shares at $15.00-$17.00 per share. J.P. Morgan and BofA Merrill Lynch acted as the underwriters for the IPO and Barclays was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Eidos Therapeutics investors own include Bristol Myers Squibb (BMY), CRISPR Therapeutics (CRSP), Exelixis (EXEL), NVIDIA (NVDA), Micron Technology (MU), Axsome Therapeutics (AXSM) and Occidental Petroleum (OXY).

Company Calendar

Last Earnings
10/29/2020
Today
7/11/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:EIDX
CIK
N/A
Fax
N/A
Employees
70
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($1.03)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$37.83 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-65.21%
Return on Assets
-53.04%

Debt

Debt-to-Equity Ratio
0.14
Current Ratio
11.10
Quick Ratio
11.10

Sales & Book Value

Annual Sales
$26.69 million
Price / Sales
177.99
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$4.57 per share
Price / Book
26.74

Miscellaneous

Outstanding Shares
38,873,000
Free Float
N/A
Market Cap
$4.75 billion
Optionable
Not Optionable
Beta
-0.16
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:EIDX) was last updated on 7/11/2025 by MarketBeat.com Staff
From Our Partners